APOE and Alzheimer disease: Recent studies have shown that blocking the ability of APOE to initiate Aβ oligomerization also has a therapeutic effect—a similar approach has been successfully tested in imipramine and olanzapine preparations on 5xFAD transgenic mice, TgF344-AD transgenic rats, and a primary neuronal culture obtained from these animals [123].